Tadalafil Tablet
Product Images NDC 71335-2626

This text provides information about two sets of blood pressure measurements: Standing Diastolic BP and Supine Diastolic BP, as well as Standing Systolic BP and Supine Systolic BP. Additionally, there is reference to time in hours for both sets of measurements. It seems to be part of a data collection or monitoring process for blood pressure readings over a period of time.*

This text provides information about a medical dosage regime that involves the combination of Tadalafil 20 mg and doxazosin 8 mg for managing blood pressure issues. The chart seems to indicate some data related to systolic blood pressure levels over a period of time.*

This text provides information on the systolic blood pressure measurements at different time points after the administration of tadalafil or placebo in combination with doxazosin. The study includes doses of 20 mg tadalafil and 8 mg doxazosin at 8:00 and 20:00, as well as a placebo group with the same doxazosin dose regimen. The focus appears to be on evaluating the effects of these medications on blood pressure.*

This text provides data related to the IPSS Total Score for the treatment of participants with either Tadalafil tablets 5 mg or a placebo over a duration of 12 weeks. The change from the baseline is also indicated in the information. The significance level (*p<0.01) suggests that there was a notable difference between the two treatments in terms of efficacy.*

This description provides information about Tadalafil tablets with a dosage of 5 mg in comparison to a placebo. It also indicates statistical significance (p<0.001) and displays the duration of treatment in weeks (0, 1, 4, 8, and 12).*

This text provides information about a study with Tadalafil tablets at a dosage of 5 mg compared to a placebo. The data suggest statistical significance (p<0.01) between the two groups over a duration of treatment of up to 12 weeks.*

The provided text appears to be a description of a medication in the form of film-coated tablets containing Tadalafil USP, 10 mg each, with a National Drug Code (NDC) of 71335-2626-1. The usual dosage instructions include scanning the package insert QR code for more information. The tablets should be stored at 25°C (77°F) with permissible excursions between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature guidelines. The warning advises to keep the tablets out of reach of children and to dispense in a tight container. The medication should not be split, and the full dose should be taken. Manufacturing and repackaging information is also provided.*